Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Staar Surgical Company (NQ: STAA )

26.58 -0.05 (-0.19%)
Streaming Delayed Price Updated: 12:18 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Staar Surgical Company

< Previous 1 2 3 4 5 6 7 8 Next >
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 23, 2022
From STAAR Surgical Company
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to... 
Via Benzinga
STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Company (STAA) Q3 2021 Earnings Call Transcript
STAA earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
STAAR Surgical Reports Third Quarter Net Sales of $58.4 Million Up 24% Y/Y
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Third Quarter Results on November 3, 2021
From STAAR Surgical Company
Via Business Wire
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.... 
Via Benzinga
Down More Than 18% in 3 Months, Is STAAR Surgical Still A Buy?
Its valuation might be a sticking point. 
Via The Motley Fool
Penumbra Stock Registers A Healthy RS Rating
Penumbra shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81. 
Via Investor's Business Daily
Cramer Gives His Opinion On Amazon, WM Technology And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes STAAR Surgical Company (NASDAQ: STAA). He doesn't understand why it's not bought by someone.... 
Via Benzinga
Barron's Latest Picks And Pans: Activision, Boeing, Carvana, Moderna, Wendy's And More
This weekend's Barron's cover story takes a close look at what it will take to fix Boeing. Other featured articles discuss reliable growth stocks, whether inflation is... 
Via Benzinga
Staar Surgical Stock Scores Relative Strength Rating Upgrade
Staar Surgical stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an increase from 89 to 95. 
Via Investor's Business Daily
STAAR Surgical Stock Surges 21% After Q2 Sales Beat Expectations; Uplifts FY21 Outlook
STAAR Surgical Company (NASDAQ: STAA) Q2 sales increased 77% Y/Y to $62.4 million and up 23% on a sequential basis, beating the consensus of $52.56 million. The... 
Via Benzinga
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nautilus Biotechnology (NASDAQ:NAUT) stock rose 25.23% to $9.38 during Thursday's regular session. Nautilus Biotechnology's stock is trading at a volume of... 
Via Benzinga
STAAR Surgical Company (STAA) Q2 2021 Earnings Call Transcript
STAA earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021
From STAAR Surgical Company
Via Business Wire
99 Biggest Movers From Yesterday
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a... 
Via Benzinga
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to... 
Via Benzinga
STAAR Surgical to Report Second Quarter Results on August 4, 2021
From STAAR Surgical Company
Via Business Wire
Align Technology Stock Trading Near Top Of Buy Zone With Earnings On Deck
To build your earnings season watch list, look for stocks in or near a potential buy range ahead of their next quarterly report. Align Technology currently fits that bill. It's... Read More 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 9, 2021
h2>Upgrades According to HSBC, the prior rating for NIO Inc (NYSE: 
Via Benzinga
Glaukos Stock Sees Its Relative Strength Rating Improve To Key Above-80 Level
Glaukos stock had its Relative Strength (RS) Rating upgraded from 78 to 81 Thursday. Is Glaukos on your watchlist? 
Via Investor's Business Daily
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 145 companies set new 52-week highs. Noteworthy Highlights: The largest company by market cap to hit a new 52-week high was Microsoft... 
Via Benzinga
Stocks That Hit 52-Week Highs On Friday
Friday's morning session saw 39 companies set new 52-week highs. Areas of Significance: The largest company by market cap to set a new 52-week high was NVIDIA (... 
Via Benzinga
Edwards Lifesciences Stock Gets Revived With Relative Strength Rating Upgrade
The Relative Strength (RS) Rating for Edwards Lifesciences stock headed into a higher percentile Tuesday, as it got a lift from 67 to 71. 
Via Investor's Business Daily
Is It Too Late to Buy Staar Surgical Stock?
This company's eye-opening surge has people wondering if it's too late to get in on the boom. 
Via The Motley Fool
Medical Device Maker Quanterix Stock Shows Rising Relative Strength
On Friday, Quanterix stock hit an important technical milestone, with its Relative Strength (RS) Rating upgrading to 91 from 88 a day before. 
Via Investor's Business Daily
Is STAAR Surgical a Warren Buffett Stock?
He'd appreciate its margins and its moat. 
Via The Motley Fool
10x Genomics Stock Shows Rising Price Performance With Jump To 83 RS Rating
On Friday, biotech 10x Genomics stock received an upgrade to its Relative Strength (RS) Rating to 83, from 80 on Thursday. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.